SUBSCRIBE
SUBSCRIBE

Food and Drug Administration (FDA)

NEWS
BioCapital
Battleground FDA: The High Stakes of the Avandia Panel
June 5, 2013
 · 
1 min read
BioCapital
FDA Commissioner Hints at New Diagnostic Test Regulations
June 4, 2013
 · 
1 min read
BioCapital
The Hidden Agenda Behind the FDA’s New Avandia Hearings
May 23, 2013
 · 
1 min read
Policy
The Ranbaxy Laboratories Whistleblower and the Scheme to Fool the FDA
May 16, 2013
 · 
1 min read
BioCapital
What Did She Do? Congress Probes Departure of FDA Official
May 14, 2013
 · 
1 min read
Biotech Bay
Will FDA Approve Cars That Can Monitor Your Health?
April 29, 2013
 · 
1 min read
BioCapital
FDA Develops Device Capable of Recognizing Fake Anti-Malaria Drugs
April 26, 2013
 · 
1 min read
BioMidwest
FDA Outlines Path to Test Alzheimer’s Drugs Earlier
February 11, 2013
 · 
1 min read
Biotech Bay
PepsiCo to Remove Toxic Addictive From Gatorade, Will Replace With FDA Approved Ingredient
January 28, 2013
 · 
1 min read
Load More
JOBS
IN THE PRESS
Press Releases
Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis
June 29, 2026
 · 
6 min read
Press Releases
Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy
June 29, 2026
 · 
7 min read
Press Releases
Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)
June 29, 2026
 · 
14 min read
Press Releases
Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia
June 29, 2026
 · 
14 min read
Press Releases
SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease
June 28, 2026
 · 
13 min read
Press Releases
Anivive Lifesciences Announces FDA Approval of Laverdia®, the First Oral Treatment of Its Kind for Canine Lymphoma
June 28, 2026
 · 
4 min read
Press Releases
Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
June 28, 2026
 · 
6 min read
Press Releases
PharmaEssentia Announces FDA Approval and U.S. Launch of BESREMi Pen™ (ropeginterferon alfa-2b-njft) for Polycythemia Vera
June 26, 2026
 · 
5 min read
Press Releases
Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma
June 26, 2026
 · 
4 min read
Press Releases
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS ≥10) Advanced Triple-Negative Breast Cancer (TNBC)
June 25, 2026
 · 
19 min read
Load More